NL-OMON31345尚未招募不适用
Hepatic insulin resistance and Dopaminergic dysfunction in a Ultra High Risk (UHR) population for Schizophrenia - IHR-HIR
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Ultra high risk symptoms for development of psychosis as defined by McGorry et al (2002).
- •Healthy controls matched for age, sex, BMI, IQ, ethnicity, viceral and subcutanious fat mass.
排除标准
- •Previous psychotic episode
- •Previous use of antipsychotics, or regular use of cocaine or amphetamins
- •Type I and II diabetes mellitus
- •Renal insufficiency
- •Family history for type II diabetes mellitus.
- •Familial dyslipidemia
- •Treatment with drugs which are known to interfere with glucose or lipid metabolism
- •Alcohol consumption in excess of 3 units per day or in the last 3 days before the clamp
研究者
相似试验
已完成
不适用
Raclopride-PET/MRTDiabetes Mellitus, Type 2NCT03637075University Hospital Tuebingen24
已完成
不适用
Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Haloperidol in Healthy HumansInsulin ResistanceDyslipidemiaNCT00625014Leiden University Medical Center8
已完成
不适用
Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy HumansInsulin ResistanceDyslipidemiaNCT00625170Leiden University Medical Center11
已完成
不适用
Assessment of Liver Glucose Metabolism in Diabetic SubjectsNewly Diagnosed Type 2 Diabetes (During the Last 12 Months)NCT01397279German Diabetes Center22
已完成
不适用
Dopamine and Insulin ResistanceObesityNCT00802204Vanderbilt University28